메뉴 건너뛰기




Volumn 8, Issue 1, 2017, Pages

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance

(53)  Somasundaram, Rajasekharan a   Zhang, Gao a   Fukunaga Kalabis, Mizuho a   Perego, Michela a   Krepler, Clemens a   Xu, Xiaowei b   Wagner, Christine c   Hristova, Denitsa a   Zhang, Jie d   Tian, Tian d   Wei, Zhi d   Liu, Qin a   Garg, Kanika c   Griss, Johannes c   Hards, Rufus a   Maurer, Margarita c   Hafner, Christine e   Mayerhöfer, Marius f   Karanikas, Georgios f   Jalili, Ahmad c   more..


Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE INHIBITOR; DACARBAZINE; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE INHIBITOR; OFATUMUMAB; SOMATOMEDIN C; ANTINEOPLASTIC AGENT; B RAF KINASE; BRAF PROTEIN, HUMAN; CISPLATIN; FGFR3 PROTEIN, HUMAN; IGF1 PROTEIN, HUMAN; MONOCLONAL ANTIBODY; PACLITAXEL; PROTEIN KINASE INHIBITOR;

EID: 85029869610     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-017-00452-4     Document Type: Article
Times cited : (109)

References (59)
  • 2
    • 84942517244 scopus 로고    scopus 로고
    • Nivolumab in combination with ipilimumab for the treatment of melanoma
    • Somasundaram, R. & Herlyn, M. Nivolumab in combination with ipilimumab for the treatment of melanoma. Expert Rev. Anticancer Ther. 15, 1135-1141 (2015).
    • (2015) Expert Rev. Anticancer Ther. , vol.15 , pp. 1135-1141
    • Somasundaram, R.1    Herlyn, M.2
  • 3
    • 84864285794 scopus 로고    scopus 로고
    • Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
    • Straussman, R. et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature. 487, 500-504 (2012).
    • (2012) Nature. , vol.487 , pp. 500-504
    • Straussman, R.1
  • 4
    • 78650008177 scopus 로고    scopus 로고
    • Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K
    • Villanueva, J. et al. Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K. Cancer Cell 18, 683-695 (2010).
    • (2010) Cancer Cell , vol.18 , pp. 683-695
    • Villanueva, J.1
  • 5
    • 84898738821 scopus 로고    scopus 로고
    • BRAF inhibitor resistance mechanisms in metastatic melanoma: Spectrum and clinical impact
    • Rizos, H. et al. BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact. Clin. Cancer Res. 20, 1965-1977 (2014).
    • (2014) Clin. Cancer Res. , vol.20 , pp. 1965-1977
    • Rizos, H.1
  • 6
    • 82955172970 scopus 로고    scopus 로고
    • Fibroblasts contribute to melanoma tumor growth and drug resistance
    • Flach, E. H., Rebecca, V. W., Herlyn, M., Smalley, K. S. & Anderson, A. R. Fibroblasts contribute to melanoma tumor growth and drug resistance. Mol. Pharm. 8, 2039-2049 (2011).
    • (2011) Mol. Pharm. , vol.8 , pp. 2039-2049
    • Flach, E.H.1    Rebecca, V.W.2    Herlyn, M.3    Smalley, K.S.4    Anderson, A.R.5
  • 7
    • 84858590826 scopus 로고    scopus 로고
    • Accessories to the crime: Functions of cells recruited to the tumor microenvironment
    • Hanahan, D. & Coussens, L. M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21, 309-322 (2012).
    • (2012) Cancer Cell , vol.21 , pp. 309-322
    • Hanahan, D.1    Coussens, L.M.2
  • 8
    • 80053401068 scopus 로고    scopus 로고
    • Breast cancer stem cells, cytokine networks, and the tumor microenvironment
    • Korkaya, H., Liu, S. & Wicha, M. S. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J. Clin. Invest. 121, 3804-3809 (2011).
    • (2011) J. Clin. Invest. , vol.121 , pp. 3804-3809
    • Korkaya, H.1    Liu, S.2    Wicha, M.S.3
  • 9
    • 84857746620 scopus 로고    scopus 로고
    • Immunotype and immunohistologic characteristics of tumorinfiltrating immune cells are associated with clinical outcome in metastatic melanoma
    • Erdag, G. et al. Immunotype and immunohistologic characteristics of tumorinfiltrating immune cells are associated with clinical outcome in metastatic melanoma. Cancer Res. 72, 1070-1080 (2012).
    • (2012) Cancer Res. , vol.72 , pp. 1070-1080
    • Erdag, G.1
  • 10
    • 84862001719 scopus 로고    scopus 로고
    • A seven-marker signature and clinical outcome in malignant melanoma: A large-scale tissue-microarray study with two independent patient cohorts
    • Meyer, S. et al. A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLoS ONE 7, e38222 (2012).
    • (2012) PLoS ONE , vol.7 , pp. e38222
    • Meyer, S.1
  • 11
    • 84971505166 scopus 로고    scopus 로고
    • Tumor associated B cells in cutaneous primary melanoma and improved clinical outcome
    • 54, 157-164
    • Garg, K. et al. Tumor associated B cells in cutaneous primary melanoma and improved clinical outcome. Hum. Pathol. 54, 157-164 (2016). 54, 157-164
    • (2016) Hum. Pathol. , vol.54 , pp. 157-164
    • Garg, K.1
  • 12
    • 84911166897 scopus 로고    scopus 로고
    • A significant percentage of CD20-positive TILs correlates with poor prognosis in patients with primary cutaneous malignant melanoma
    • Martinez-Rodriguez, M., Thompson, A. K. & Monteagudo, C. A significant percentage of CD20-positive TILs correlates with poor prognosis in patients with primary cutaneous malignant melanoma. Histopathology 65, 726-728 (2014).
    • (2014) Histopathology , vol.65 , pp. 726-728
    • Martinez-Rodriguez, M.1    Thompson, A.K.2    Monteagudo, C.3
  • 13
    • 84878448880 scopus 로고    scopus 로고
    • B cells promote tumor progression via STAT3 regulatedangiogenesis
    • Yang, C. et al. B cells promote tumor progression via STAT3 regulatedangiogenesis. PLoS ONE 8, e64159 (2013).
    • (2013) PLoS ONE , vol.8 , pp. e64159
    • Yang, C.1
  • 14
    • 80051484018 scopus 로고    scopus 로고
    • B lymphocytes promote lymphogenous metastasis of lymphoma and melanoma
    • Ruddell, A., Harrell, M. I., Furuya, M., Kirschbaum, S. B. & Iritani, B. M. B lymphocytes promote lymphogenous metastasis of lymphoma and melanoma. Neoplasia 13, 748-757 (2011).
    • (2011) Neoplasia , vol.13 , pp. 748-757
    • Ruddell, A.1    Harrell, M.I.2    Furuya, M.3    Kirschbaum, S.B.4    Iritani, B.M.5
  • 15
    • 54249161032 scopus 로고    scopus 로고
    • A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: Evidence from mice and humans
    • Staquicini, F. I. et al. A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans. Cancer Res. 68, 8419-8428 (2008).
    • (2008) Cancer Res. , vol.68 , pp. 8419-8428
    • Staquicini, F.I.1
  • 16
    • 19344365408 scopus 로고    scopus 로고
    • De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
    • de Visser, K. E., Korets, L. V. & Coussens, L. M. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7, 411-423 (2005).
    • (2005) Cancer Cell , vol.7 , pp. 411-423
    • De Visser, K.E.1    Korets, L.V.2    Coussens, L.M.3
  • 17
    • 84902465821 scopus 로고    scopus 로고
    • B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas
    • Affara, N. I. et al. B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas. Cancer Cell 25, 809-821 (2014).
    • (2014) Cancer Cell , vol.25 , pp. 809-821
    • Affara, N.I.1
  • 18
    • 84960124795 scopus 로고    scopus 로고
    • Bruton's tyrosine kinase (BTK)-dependent immune cell crosstalk drives pancreas cancer
    • Gunderson, A. J. et al. Bruton's tyrosine kinase (BTK)-dependent immune cell crosstalk drives pancreas cancer. Cancer Discov. 6, 270-285 (2016).
    • (2016) Cancer Discov. , vol.6 , pp. 270-285
    • Gunderson, A.J.1
  • 19
    • 84960123964 scopus 로고    scopus 로고
    • Hif1alpha deletion reveals pro-neoplastic function of B cells in pancreatic neoplasia
    • Lee, K. E. et al. Hif1alpha deletion reveals pro-neoplastic function of B cells in pancreatic neoplasia. Cancer Discov. 6, 256-269 (2016).
    • (2016) Cancer Discov. , vol.6 , pp. 256-269
    • Lee, K.E.1
  • 20
    • 77949379050 scopus 로고    scopus 로고
    • B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
    • Ammirante, M., Luo, J. L., Grivennikov, S., Nedospasov, S. & Karin, M. B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature. 464, 302-305 (2010).
    • (2010) Nature , vol.464 , pp. 302-305
    • Ammirante, M.1    Luo, J.L.2    Grivennikov, S.3    Nedospasov, S.4    Karin, M.5
  • 21
    • 0035477424 scopus 로고    scopus 로고
    • Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways
    • Satyamoorthy, K., Li, G., Vaidya, B., Patel, D. & Herlyn, M. Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways. Cancer Res. 61, 7318-7324 (2001).
    • (2001) Cancer Res. , vol.61 , pp. 7318-7324
    • Satyamoorthy, K.1    Li, G.2    Vaidya, B.3    Patel, D.4    Herlyn, M.5
  • 22
    • 84884368877 scopus 로고    scopus 로고
    • Influence of tumour micro-environment heterogeneity on therapeutic response
    • Junttila, M. R. & de Sauvage, F. J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 501, 346-354 (2013).
    • (2013) Nature. , vol.501 , pp. 346-354
    • Junttila, M.R.1    De Sauvage, F.J.2
  • 23
    • 27144557960 scopus 로고    scopus 로고
    • A tumorigenic subpopulation with stem cell properties in melanomas
    • Fang, D. et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 65, 9328-9337 (2005).
    • (2005) Cancer Res , vol.65 , pp. 9328-9337
    • Fang, D.1
  • 25
    • 57849117384 scopus 로고    scopus 로고
    • New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1. 1)
    • Eisenhauer, E. A. et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1. 1). Eur. J. Cancer 45, 228-247 (2009).
    • (2009) Eur. J. Cancer , vol.45 , pp. 228-247
    • Eisenhauer, E.A.1
  • 26
    • 73149092567 scopus 로고    scopus 로고
    • Guidelines for the evaluation of immune therapy activity in solid tumors: Immune-related response criteria
    • Wolchok, J. D. et al. Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Clin. Cancer Res. 15, 7412-7420 (2009).
    • (2009) Clin. Cancer Res. , vol.15 , pp. 7412-7420
    • Wolchok, J.D.1
  • 27
    • 84873668054 scopus 로고    scopus 로고
    • Tumor-infiltrating B cells: The ignored players in tumor immunology
    • Linnebacher, M. & Maletzki, C. Tumor-infiltrating B cells: the ignored players in tumor immunology. Oncoimmunology 1, 1186-1188 (2012).
    • (2012) Oncoimmunology , vol.1 , pp. 1186-1188
    • Linnebacher, M.1    Maletzki, C.2
  • 28
    • 84862557227 scopus 로고    scopus 로고
    • CD20+ tumor-infiltrating lymphocytes have an atypical CD27-memory phenotype and together with CD8+T cells promote favorable prognosis in ovarian cancer
    • Nielsen, J. S. et al. CD20+ tumor-infiltrating lymphocytes have an atypical CD27-memory phenotype and together with CD8+T cells promote favorable prognosis in ovarian cancer. Clin. Cancer Res. 18, 3281-3292 (2012).
    • (2012) Clin. Cancer Res. , vol.18 , pp. 3281-3292
    • Nielsen, J.S.1
  • 29
    • 84872229121 scopus 로고    scopus 로고
    • Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancer
    • Yang, C. et al. Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancer. PLoS ONE 8, e54029 (2013).
    • (2013) PLoS ONE , vol.8 , pp. e54029
    • Yang, C.1
  • 30
    • 82355169702 scopus 로고    scopus 로고
    • Prognostic impact of B-cell density in cutaneous melanoma
    • Ladanyi, A. et al. Prognostic impact of B-cell density in cutaneous melanoma. Cancer Immunol. Immunother. 60, 1729-1738 (2011).
    • (2011) Cancer Immunol. Immunother. , vol.60 , pp. 1729-1738
    • Ladanyi, A.1
  • 31
    • 78149488860 scopus 로고    scopus 로고
    • CD20+B cells: The other tumor-infiltrating lymphocytes
    • Nelson, B. H. CD20+B cells: the other tumor-infiltrating lymphocytes. J. Immunol. 185, 4977-4982 (2010).
    • (2010) J. Immunol. , vol.185 , pp. 4977-4982
    • Nelson, B.H.1
  • 32
    • 84893203731 scopus 로고    scopus 로고
    • Tumor infiltrating B-cells are increased in prostate cancer tissue
    • Woo, J. R. et al. Tumor infiltrating B-cells are increased in prostate cancer tissue. J. Transl. Med. 12, 30 (2014).
    • (2014) J. Transl. Med. , vol.12 , pp. 30
    • Woo, J.R.1
  • 33
    • 84960076087 scopus 로고    scopus 로고
    • IL-35 producing B cells promote the development of pancreatic neoplasia
    • 6, 247-255
    • Pylayeva-Gupta, Y. et al. IL-35 producing B cells promote the development of pancreatic neoplasia. Cancer Discov. 6, 247-255 (2015). 6, 247-255
    • (2015) Cancer Discov. , vol.6 , pp. 247-255
    • Pylayeva-Gupta, Y.1
  • 34
    • 84929085260 scopus 로고    scopus 로고
    • Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
    • Shalapour, S. et al. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature 521, 94-98 (2015).
    • (2015) Nature , vol.521 , pp. 94-98
    • Shalapour, S.1
  • 36
    • 61649100307 scopus 로고    scopus 로고
    • The FGF family: Biology, pathophysiology and therapy
    • Beenken, A. & Mohammadi, M. The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug. Discov. 8, 235-253 (2009).
    • (2009) Nat. Rev. Drug. Discov. , vol.8 , pp. 235-253
    • Beenken, A.1    Mohammadi, M.2
  • 37
    • 84928174677 scopus 로고    scopus 로고
    • Therapy-induced tumour secretomes promote resistance and tumour progression
    • Obenauf, A. C. et al. Therapy-induced tumour secretomes promote resistance and tumour progression. Nature 520, 368-372 (2015).
    • (2015) Nature , vol.520 , pp. 368-372
    • Obenauf, A.C.1
  • 38
    • 79952302092 scopus 로고    scopus 로고
    • Eradication of melanomas by targeted elimination of a minor subset of tumor cells
    • Schmidt, P. et al. Eradication of melanomas by targeted elimination of a minor subset of tumor cells. Proc. Natl Acad. Sci. USA 108, 2474-2479 (2011).
    • (2011) Proc. Natl Acad. Sci. USA , vol.108 , pp. 2474-2479
    • Schmidt, P.1
  • 39
    • 84864994126 scopus 로고    scopus 로고
    • Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma
    • Yadav, V. et al. Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma. J. Biol. Chem. 287, 28087-28098 (2012).
    • (2012) J. Biol. Chem. , vol.287 , pp. 28087-28098
    • Yadav, V.1
  • 40
    • 80052866912 scopus 로고    scopus 로고
    • Fibroblast growth factor receptors as therapeutic targets in human melanoma: Synergism with BRAF inhibition
    • Metzner, T. et al. Fibroblast growth factor receptors as therapeutic targets in human melanoma: synergism with BRAF inhibition. J. Invest. Dermatol. 131, 2087-2095 (2011).
    • (2011) J. Invest. Dermatol. , vol.131 , pp. 2087-2095
    • Metzner, T.1
  • 41
    • 74949143594 scopus 로고    scopus 로고
    • Final version of 2009 AJCC melanoma staging and classification
    • Balch, C. M. et al. Final version of 2009 AJCC melanoma staging and classification. J. Clin. Oncol. 27, 6199-6206 (2009).
    • (2009) J. Clin. Oncol. , vol.27 , pp. 6199-6206
    • Balch, C.M.1
  • 42
    • 0021341671 scopus 로고
    • Inhibition of the mitogenic effects of plasma by a monoclonal antibody to somatomedin C
    • Russell, W. E., Van Wyk, J. J. & Pledger, W. J. Inhibition of the mitogenic effects of plasma by a monoclonal antibody to somatomedin C. Proc. Natl Acad. Sci. USA 81, 2389-2392 (1984).
    • (1984) Proc. Natl Acad. Sci. USA , vol.81 , pp. 2389-2392
    • Russell, W.E.1    Van Wyk, J.J.2    Pledger, W.J.3
  • 43
    • 35848956117 scopus 로고    scopus 로고
    • Upregulation of IGF-2 and IGF-1 receptor expression in oral cancer cell lines
    • Brady, G., Crean, S. J., Naik, P. & Kapas, S. Upregulation of IGF-2 and IGF-1 receptor expression in oral cancer cell lines. Int. J. Oncol. 31, 875-881 (2007).
    • (2007) Int. J. Oncol. , vol.31 , pp. 875-881
    • Brady, G.1    Crean, S.J.2    Naik, P.3    Kapas, S.4
  • 44
    • 1642422358 scopus 로고    scopus 로고
    • The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation
    • Cheung, C. W., Vesey, D. A., Nicol, D. L. & Johnson, D. W. The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation. Kidney. Int. 65, 1272-1279 (2004).
    • (2004) Kidney. Int. , vol.65 , pp. 1272-1279
    • Cheung, C.W.1    Vesey, D.A.2    Nicol, D.L.3    Johnson, D.W.4
  • 45
    • 0034650596 scopus 로고    scopus 로고
    • CD4(+), HLA class I-restricted, cytolytic Tlymphocyte clone against primary malignant melanoma cells
    • Somasundaram, R. et al. CD4(+), HLA class I-restricted, cytolytic Tlymphocyte clone against primary malignant melanoma cells. Int. J. Cancer 85, 253-259 (2000).
    • (2000) Int. J. Cancer , vol.85 , pp. 253-259
    • Somasundaram, R.1
  • 46
    • 0141613181 scopus 로고    scopus 로고
    • An efficient method for the rapid establishment of Epstein-Barr virus immortalization of human B lymphocytes
    • Oh, H. M. et al. An efficient method for the rapid establishment of Epstein-Barr virus immortalization of human B lymphocytes. Cell Prolif. 36, 191-197 (2003).
    • (2003) Cell Prolif. , vol.36 , pp. 191-197
    • Oh, H.M.1
  • 47
    • 84890774497 scopus 로고    scopus 로고
    • Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target
    • Rasanen, K. et al. Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target. Mol. Cell Proteomics 12, 3778-3792 (2013).
    • (2013) Mol. Cell Proteomics , vol.12 , pp. 3778-3792
    • Rasanen, K.1
  • 48
    • 77957069138 scopus 로고    scopus 로고
    • Detection of individual endogenous RNA transcripts in situ using multiple singly labeled probes
    • Raj, A. & Tyagi, S. Detection of individual endogenous RNA transcripts in situ using multiple singly labeled probes. Methods Enzymol. 472, 365-386 (2010).
    • (2010) Methods Enzymol. , vol.472 , pp. 365-386
    • Raj, A.1    Tyagi, S.2
  • 49
    • 46249088370 scopus 로고    scopus 로고
    • Lumi: A pipeline for processing Illumina microarray
    • Du, P., Kibbe, W. A. & Lin, S. M. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24, 1547-1548 (2008).
    • (2008) Bioinformatics , vol.24 , pp. 1547-1548
    • Du, P.1    Kibbe, W.A.2    Lin, S.M.3
  • 50
    • 84988531155 scopus 로고    scopus 로고
    • Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors
    • Zhang, G. et al. Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors. J. Clin. Invest. 126, 1-41 (2016).
    • (2016) J. Clin. Invest. , vol.126 , pp. 1-41
    • Zhang, G.1
  • 51
    • 84926332167 scopus 로고    scopus 로고
    • Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma
    • Kwong, L. N. et al. Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma. J. Clin. Invest. 125, 1459-1470 (2015).
    • (2015) J. Clin. Invest. , vol.125 , pp. 1459-1470
    • Kwong, L.N.1
  • 52
    • 84897397058 scopus 로고    scopus 로고
    • FeatureCounts: An efficient general purpose program for assigning sequence reads to genomic features
    • Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923-930 (2014).
    • (2014) Bioinformatics , vol.30 , pp. 923-930
    • Liao, Y.1    Smyth, G.K.2    Shi, W.3
  • 53
    • 33645531525 scopus 로고    scopus 로고
    • Human leukocyte antigen-A2-restricted CTL responses to mutated BRAF peptides in melanoma patients
    • Somasundaram, R. et al. Human leukocyte antigen-A2-restricted CTL responses to mutated BRAF peptides in melanoma patients. Cancer Res. 66, 3287-3293 (2006).
    • (2006) Cancer Res. , vol.66 , pp. 3287-3293
    • Somasundaram, R.1
  • 54
    • 84877001084 scopus 로고    scopus 로고
    • Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence
    • Aird, K. M. et al. Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. Cell Rep. 3, 1252-1265 (2013).
    • (2013) Cell Rep. , vol.3 , pp. 1252-1265
    • Aird, K.M.1
  • 55
    • 84860531228 scopus 로고    scopus 로고
    • Targeting CD20 in melanoma patients at high risk of disease recurrence
    • Pinc, A. et al. Targeting CD20 in melanoma patients at high risk of disease recurrence. Mol. Ther. 20, 1056-1062 (2012).
    • (2012) Mol. Ther. , vol.20 , pp. 1056-1062
    • Pinc, A.1
  • 56
    • 0030853288 scopus 로고    scopus 로고
    • Melanoma cell lines from different stages of progression and their biological and molecular analyses
    • Satyamoorthy, K. et al. Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res. 7, S35-42 (1997).
    • (1997) Melanoma Res. , vol.7 , pp. S35-42
    • Satyamoorthy, K.1
  • 57
    • 84855441276 scopus 로고    scopus 로고
    • Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma
    • Xu, X. et al. Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma. Clin. Cancer Res. 18, 229-237 (2011).
    • (2011) Clin. Cancer Res. , vol.18 , pp. 229-237
    • Xu, X.1
  • 58
    • 84864764964 scopus 로고    scopus 로고
    • Differentiation-induced skin cancer suppression by FOS p53, and TACE/ADAM17
    • Guinea-Viniegra, J. et al. Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17. J. Clin. Invest. 122, 2898-2910 (2012).
    • (2012) J. Clin. Invest. , vol.122 , pp. 2898-2910
    • Guinea-Viniegra, J.1
  • 59
    • 84869213410 scopus 로고    scopus 로고
    • Quantitative immunofluorescence reveals the signature of active B-cell receptor signaling in diffuse large B-cell lymphoma
    • Bogusz, A. M. et al. Quantitative immunofluorescence reveals the signature of active B-cell receptor signaling in diffuse large B-cell lymphoma. Clin. Cancer Res. 18, 6122-6135 (2012).
    • (2012) Clin. Cancer Res. , vol.18 , pp. 6122-6135
    • Bogusz, A.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.